GPTHEALTHBSEGPT Healthcare LtdHighNeutral
Announced Mon, 18 May · 18:38 IST

Please find enclosed press release on Q4FY202526 results

Revenue Growth 20pctPat NegativeEbitda Margin CompressionResults View source PDF

GPTHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.7%1-day move
₹139.98
prior close
₹140.84
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.8+0.8+0.7+3.0+1.7+0.7+0.1-0.2-0.2+1.8+5.7+5.7+6.1
Up moveDown movePending
AI summary

GPT Healthcare reported Q4FY26 revenue of Rs. 128.0 crore, up 24.30% YoY, driven by higher patient volumes and improved occupancy. However, EBITDA margin compressed to 19.53% from 21.62% in Q4FY25 due to new facility ramp-up costs. Full-year FY26 revenue grew 15.14% to Rs. 478.5 crore, but PAT declined 15.43% to Rs. 42.2 crore and EBITDA margin fell to 18.84% from 22.10% in FY25. The company launched the Raipur Hospital during the year, installed robotic surgery technology, and signed an MoU for a 150-bed Jamshedpur facility targeting FY27 commissioning.

Likely market impact

Revenue growth is strong, but margin compression and PAT decline for the full year may concern investors, as new facility costs and expansion investments impacted profitability despite higher volumes.